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INTRODUCTION
In order to divide, bacteria must synthesize a new septal cell wall, which must be split down the middle by one or more murein hydrolases to separate the resulting daughter cells. The precise molecular mechanism underlying this fundamental process is still poorly understood in most bacteria. In the present investigation, we have studied the septal cross wall-splitting mechanism in the Gram-positive bacterium Streptococcus pneumoniae. In addition to its important biological implications, this process might be worthy for therapeutic targeting since S. pneumoniae is a major human pathogen that has become increasingly resistant to antibiotics in recent decades 1 . Thus, new drugs and new drug targets are urgently sought.
The peptidoglycan (PG), the major constituent of the cell wall, is essential for bacterial survival. Its synthesis and turnover involve a number of enzymes that must function in a coordinated manner. During the last decade it has become clear that a twocomponent regulatory system termed WalKR (also known as VicKR and YycGF) controls peptidoglycan metabolism in low G+C Gram-positive bacteria 2 . Analysis of the WalKR regulons of Bacillus subtilis and Staphylococcus aureus have revealed their role in the control of the expression of a number of peptidoglycan hydrolases, some of which are involved in the separation of daughter cells 3, 4 . Similarly, genes encoding several putative and proven peptidoglycan hydrolases are part of the pneumococcal WalKR regulon 5, 6 .
The product of one of these genes, PcsB (from protein required for cell wall separation of group B streptococcus), has been shown to be essential for viability in S. pneumoniae strains D39 and R6 7 . PcsB is a secreted putative murein hydrolase that localizes to the septal area. It has been characterized to various degrees in S. pneumoniae 8, 9 ,
Streptococcus mutans (where it is called GbpB) 10 , and Streptococcus agalactiae 11 . In all cases, it has been shown to be required for normal growth and cell division. Homologs of PcsB are present in all members of the genera Streptococcus and Lactococcus.
Judging from its primary structure, PcsB consists of four parts: an N-terminal signal peptide, a coiled-coil (CC) domain containing putative leucine zipper motifs, an alaninerich linker region and a C-terminal cysteine, histidine-dependent amidohydrolase/peptidase (CHAP) domain. Despite the presence of this putative catalytic domain in the PcsB sequence, attempts to demonstrate hydrolytic activity of full-length
PcsB have been unsuccessful 8, 11, 12 . Recently it was discovered that PcsB interacts with the membrane-embedded protein FtsX through its N-terminal coiled-coil domain. FtsX has two extracellular loops, ECL1 and ECL2, which are involved in this interaction 13, 14 . At the cytoplasmic side of the membrane, FtsX, which has four transmembrane segments, interacts with FtsE. An increasing body of knowledge indicates that the FtsEX complex is an essential regulator of murein-hydrolase activity in Gram-positive as well as Gramnegative bacteria 15 . FtsE is an ATPase, and it is therefore believed that ATP hydrolysis drives a conformational change in the FtsEX/PcsB complex that activates PcsB.
Recently PcsB has emerged as a leading candidate for a new-generation pneumococcal vaccine. Depending on the vaccine type, pneumococcal vaccine formulations in current use contain a mixture of 7-23 capsular polysaccharides, making them costly to produce and with limited serotype coverage. In addition, since there are at least 90 different capsular varieties, serotype replacement and capsular switching will eventually enable pneumococci to evade capsule-based vaccines. A promising alternative is the use of conserved nonpolysaccharide antigens 16 . PcsB, which is a surface-exposed and exceptionally conserved protein (>99.5% identity) among clinical isolates of S.
pneumoniae, has demonstrated its efficacy in lethal models of sepsis and pneumonia 17 .
In the present report we show that depletion of PcsB in S. pneumoniae strain R6, inhibits daughter-cell separation without affecting the synthesis of new septal cross walls.
We also provide strong evidence that the C-terminal CHAP domain of PcsB exhibits muralytic activity. Furthermore, the full-length pneumococcal PcsB protein was expressed, purified to homogeneity, crystallized and its structure determined. The structure displays a striking arrangement of the coiled-coil and catalytic domains, which associate forming a dimer through three-dimensional domain swapping. In solution the protein is present in a monomer-dimer equilibrium. Analysis of the structure, together with biochemical and biophysical characterization, have provided new insights into the catalytic mechanism of PcsB, revealing the regulatory role played by the PcsB-FtsEX complex during daughter cell separation.
RESULTS

Effect of PcsB depletion on cross wall synthesis and cell separation
In Gram-negative bacteria, synthesis and splitting of the new cross wall take place in close succession, leading to a gradual constriction of the whole bacterial cell that culminates in separation. On the other hand, in Gram-positives have been reported that the complete cross wall is synthesized before muralytic enzymes cleave it 18 . To determine whether synthesis of the peptidoglycan cross wall is independent of cross-wall splitting we performed transmission-electron microscopy studies (TEM) of PcsB-depleted S.
pneumoniae R6 cells. In intermediately depleted R6 cells, the first sign of PcsB deficiency is uncleaved cross walls. As seen in Supplementary Fig. 1 , the original cell wall separating the first-generation daughter cells has not been cleaved, even though the second-generation daughter cells are separated by fully formed cross walls. In severely depleted cells, most new cross walls are misplaced. In these cells synthesis of the next septum can start anywhere from the internal surface of the cell and, in many cases, it grows at a skewed angle relative to the cell's long axis. As shown in Supplementary Fig.   1C , a new cross wall can even assemble on top of and at a right angle to an old cross wall.
Together these results show three important facts about PcsB-depleted R6 cells: i) splitting of peptidoglycan cross walls are inhibited already in intermediately depleted cells, ii) the lack of PcsB does not inhibit the synthesis of new cross walls, and iii) strongly depleted cells lose their spatial orientation and initiates synthesis of new cross walls at random. The last effect may explain why PcsB is essential in the R6 strain. For reasons unknown, some pneumococcal strains are able to survive without PcsB. Deletion of the pcsB gene in these strains gives rise to very sick cells with phenotypes that are highly similar to those depicted in Supplementary Fig. 1 17 .
Overall structure of PcsB
The crystal structure of the wild-type PcsB was solved at 2.5 Å resolution by the SAD technique (see Methods). The asymmetric unit of PcsB consists of two monomers arranged in a 164-Å long dimer (Fig. 1a) . Each monomer is composed of three distinct regions: a coiled-coil domain (residues 41-266), a linker region (residues 267-278) and a CHAP domain (residues 279-392) ( Fig. 1b and Supplementary Fig. 2) . Structures of the two monomers show C α backbone rmsd (root mean squared deviation) of 1.82 Å; as the domains are nearly identical (C α backbone rmsd of 1.09 Å and 0.16 Å for CC and CHAP domains respectively) this value is due to a slight difference in modular arrangement between CC and CHAP domains for each monomer (Supplementary Fig. 3) . Thus, hereafter, we limit our discussion to one PcsB molecule (Chain A). The whole structure can be roughly encased in an acute triangle of two long sides (~112 and ~118 Å) and a short side of ~66 Å. The CC domain is arranged in five helices, three long bent helices (α1, α3 and α4) composed of a large number of residues (66, 73 and 41 aa respectively) and two short ones (α2 and α5). The electron density was of good quality for all of them except for the short α2 that also has the highest B factors. The linker region is composed of an alanine-rich region and the sequence comprised of the stretch between Pro271 to Pro278 (266-AAAPVRAKVRP-279). This region connects the end of the α5 helix of the CC domain with the globular catalytic CHAP domain. The electron density for the linker unequivocally defines the connection between the modules of one of the chains ( Supplementary Fig. 4 ), while in the other the density is of less quality probably due to crystal contacts. The catalytic domain displays an α+β papain-like amidase fold, with two α-helices (α1 c and α2 c )
and an antiparallel β-sheet built up by β1 c to β4 c (Fig. 1b) . The N-terminal lobe (α1 c -α2 c )
folds together with the C-terminal lobe, comprising the β-sheet, to build the active-site cleft (Fig. 1c) . Similar to other amidases, the reactive cysteine of PcsB, Cys292, is positioned at the N-terminal end of α1 c .
The architecture of the PcsB coiled-coil domain
The extended CC PcsB is composed of residues arranged in a continuous helical arrangement. Only the first four residues (41-45) and those of the short turns do not follow this pattern. All the helices within the CC domain are located in the same plane except for the α5 helix. The CC domain is a V-shaped molecule formed by helices α1-α3 on one side
and by α4 and α5 on the other, making an angle of ~40º (Fig. 1b) . A search for the closest structural homologues of CC PcsB with the DALI server 19 reveals that no similar structure for the complete CC has been reported previously. High structural homology is, however, found between the antiparallel α1α3 bundle of the CC domain and the human inter-SH2
domains of p85β and p85α, the regulatory subunits of phosphatidylinositol-4,5-biphosphate 3-kinase (PI3K), the tower domain of the Lys-specific histone demethylase, the molecular chaperone prefoldin and the structures of coiled-coil domains from type III secretion system translocators ( Supplementary Fig. 5 ).
Remarkably, inter-helix interactions in the CC PcsB differ depending on the helices in question: interactions between α1 and α3 are mainly mediated by hydrogen bonds and by the hydrophobic interactions of residues forming a leucine zipper (Fig. 1d) , in contrast, α3
interacts with α4 through salt links and the hydrophobic contribution is less relevant, as a consequence of the presence of less bulky alanine residues (all the Ala-rich regions, except that of the linker, are located in α4) (Fig. 1d) . Interestingly, Tyr238 is inserted at the bottom of the V-shaped conformation. Together with long-chain charged residues it opens the cavity in which the catalytic domain of the other paired monomer is located (Fig. 1d) . Fig. 6a ).
The catalytic machinery of the CHAP domain of PcsB
Papain-like hydrolytic enzymes form covalent intermediates with their substrates during the course of the reaction. A reactive cysteine acts as a catalytic nucleophile, promoted by the side chain of a histidine. The His-imidazole ring is further hydrogen-bonded to a third catalytic residue, usually an Asp or Asn. The Cys-His-Asp/Asn catalytic triad is positioned by the common structural core; the cysteine is located at the N terminus of the helix, and the histidine and the Asp/Asn are provided by the β-sheet and linking loops 20 . Sequence analysis suggested that Cys292, His343 and Asn366 are the catalytic residues in this triad.
Mutations in the first two residues (Cys292Ala and His343Ala) are not tolerated in PcsB, whereas that of Asn366Ala is 7 . Our crystal structure indicates that Asn366 is far from the Cys292 (Fig. 1c) while the Glu360 is hydrogen bonded to His343 and superimposes with the Asn175 from the catalytic triad of the papain (Supplementary Fig. 6b) . Therefore, the catalytic triad is comprised of Cys292, His343 and Glu360 (Fig. 1c) . The corresponding triad positions are also seen in the secreted CHAP domain from S. saprophyticus 21 and were shown to be the proteolytic triad in pyroglutamyl peptidases, a family of cysteine peptidases 22 . Remarkably, a strong network of salt-bridge and hydrogen-bond interactions is observed around the active site of PcsB (Fig. 1c) . Besides the expected hydrogenbonds between the catalytic triad, Glu360 is making salt-bridge interactions with both His372 and Arg373, and the last with Glu383. These interactions could modulate the PcsB activity depending on the protonation state of the corresponding amino acids.
Substrate binding in PcsB
The active site of PcsB is partially occluded by the presence of the α3 helix from the dimeric partner (Fig. 1a) , a fact that provides interesting implications for the regulatory role of the coiled-coil domain in the PcsB dimer (see discussion below). Among the peptidoglycan papain amidases, some, as for instance Spr from E. coli, have a closed active-site architecture with active-site loops blocking the active site entrance. Others like Tse1 from P. aeruginosa present an exposed active site 23 ( Supplementary Fig. 7 ).
Similar to Tse1, CHAP PcsB has an open active site with loops L1-L3 ( Fig. 1c and Supplementary Fig. 7 ) protruding outwards, creating a large groove ~31 Å long and ~7 Å wide. The active site of one monomer, chain A, showed an entrapped polyethylene glycol molecule, presumably mimicking binding of the substrate ( Fig. 2a and Supplementary Fig.   8 ). This open active site, however, is partially occluded due to the dimeric arrangement.
Very interestingly, the distance between the putative glycan strands is greater than 30 Å 24 .
Consequently, the active site of PcsB could get access to the peptide bridges that interconnect the glycan strands in the peptidoglycan sacculus.
All attempts to obtain crystals of a complex between PcsB and peptidoglycan analogues failed, very likely due to the occlusion created by the dimer arrangement. To gain insight into the substrate recognition by PcsB, we performed docking calculations with GOLD at the active site of the crystal structure ( Fig. 2a and 2b ) and place the scissile bond between isoGln and L-Lys close to the catalytic Cys292 and His343. The ligand is strongly stabilized by many hydrogen bonds and salt links with residues in the active site ( Supplementary Fig. 9 ). Remarkably, a very similar conformation for the substrate (L-Ala-D-Glu-mDAP) was found in Tse1 from P. aeruginosa 23 where mDAP is present in place of L-Lys. It has been shown that Tse1 exhibits a strong preference for the mDAP-type 23 . Our docking calculations reveal the presence of an acidic patch in the PcsB active site formed by Asp338 and Glu383 ( Fig. 2b and Supplementary Fig. 9 ), responsible of stabilization of L-Lys in the crosslinked peptidoglycan. This patch doesn't exist in Tse1, and consequently provides an explanation for the different substrate specificities of the two PG amidases.
CHAP PcsB displays murein hydrolase activity
To investigate whether full-length PcsB has muralytic activity we performed zymography with purified recombinant PcsB and pneumococcal cells mixed into the separating SDS-PAGE gel as substrate. Consistent with the results reported by others 8, 11, 12 , no muralytic activity was detected. Next, we expressed only the C-terminal CHAP domain of PcsB. For purification purposes, a 6xHis tag was attached to the N-terminal end of the domain (see Subsequent analysis of the digest by reverse phase HPLC, however, did not reveal any cleavage products. Thus, it remains for future studies to determine the cleavage specificity of PcsB.
Modular arrangement and oligomerization in PcsB
A dimeric arrangement of PcsB molecules was found in the crystal structure (Fig. 1a) . This dimer is formed by three-dimensional domain swapping 26 , in which both monomers exchange their catalytic domains in a similar way to that originally described for the dimeric structure of diphtheria toxin 27 . The dimer places both catalytic domains in the middle with their active sites oriented in opposite directions, and with the CC domain extending outwards on the same axis in a 164 Å long dimer. Analysis of the PcsB dimer by the PISA server 28 , gave a high value for the complex formation significance score (0. Table 1 ).
In agreement with crystallographic results, analytical ultracentrifugation experiments over a broad range of protein concentrations (0.1-8.0 mg/ml) revealed that the protein exists as an equilibrium mixture of dimers and monomers in solution, with dimer favored at higher protein concentrations (over 4 mg/ml) and monomer at low concentrations ( Supplementary Fig. 11 ). The monomer-dimer equilibrium presents an estimated K d of 90
µM. Interestingly, while the experimental sedimentation coefficients for the dimer are compatible with that calculated for the crystallographic dimeric structure, those for the monomer are better described by a PcsB molecule with the CHAP domain inserted in its own CC domain rather than the protein monomer observed in the asymmetric unit of our crystal ( Supplementary Fig. 11 ).
We explored whether the arrangement in the crystal is representative of PcsB in solution using small angle X-ray scattering (SAXS). The overall molecular parameters derived from the scattering data are given in Supplementary Table 2 . The scattering profiles at five different concentrations (0.29-9.40 mg/ml) ( Fig. 4 and Supplementary Fig. 12 ) indicate the presence of a monomer-dimer equilibrium, being the monomer more abundant at lower concentrations whereas the dimer is the predominant form at higher concentrations. A molecular mass of 61±6 kDa was deduced for the dimer, which is comparable to the expected dimer mass of 78 kDa (Supplementary Table 2 Table 2 ). The . 4b ) the model perfectly fits the SAXS envelope. Therefore two relevant points can be derived from this analysis; first, in solution the monomeric PcsB present an inactive conformation with the CHAP domain inserted in its own CC domain, and second, the PcsB dimer is generated by the threedimensional domain swapping of their catalytic domains.
Evidence that PcsB murolytic activity is regulated by its modular arrangement
We have previously characterized a murein hydrolase termed LytF 29 , which is produced by Streptococcus gordonii strain Challis during the competent state. LytF 42 31 .
To further verify that the function of PcsB depends on the muralytic activity of its CHAP domain, we constructed a chimera in which the CHAP domain of PcsB was replaced by the corresponding domain of LytF. LytF, which is produced by S. gordonii cells during the competent state, lyses susceptible streptococcal cells by disrupting their cell wall 29 . The gene encoding this PcsB-CHAP LytF chimera was inserted into the native pcsB locus in a strain that expressed the wild-type PcsB ectopically from the P comX promoter.
Next, the wild-type gene was deleted from the ectopic locus giving rise to strain SPH250.
Surprisingly, the SPH250 strain was viable. A homology model for the PcsB-CHAP LytF chimera was constructed (Supplementary Fig. 13 ). This model indicates that the main determinants for catalytic activity and substrate recognition were conserved between both CHAP domains. Despite some of the interactions stabilizing CC and CHAP domains in PcsB (such as a poli-Ala region) could be disturbed in the chimera (Supplementary Fig.   13 ) the strain SPH250 is viable. Its doubling time of 45 min was somewhat longer than the 35 min generation time of the parental strain. In addition, inspection of the SPH250
cultures by light microscopy revealed some enlarged misshapen cells, morphological changes reminiscent of those seen in pneumococcal cells that have been subjected to light PcsB depletion (Supplementary Fig 14) . Together, these results provide strong evidence that the CHAP domain of PcsB has muralytic activity which is regulated by the CC domain.
DISCUSSION
The crystal structure of the peptidoglycan amidase PcsB reveals a surprising arrangement of its different domains. The coiled-coil domain is a unique V-shaped molecule built by three long bent α helices and two short ones. A flexible and extended 11-aa linker connects the coiled-coil domain with the catalytic CHAP domain. Remarkably, the crystal structure of the full-length PcsB is a dimer formed by three-dimensional domain swapping in which the entire catalytic domain of one monomer is inserted in the internal cavity of the coiled-coil domain of the other (Fig. 1a and Fig. 2c) , a pattern that is also The role of the CC domain, however, goes beyond its inhibitory function. The structural framework provided by the CC domain is also required for activation of PcsB, i.e.
for cross-wall splitting and daughter-cell separation. It has been reported that a temperature sensitive (Ts) mutant containing two amino-acid changes (L79S and L218P, R6 strain numbering) in the CC domain of PcsB showed mild or severe defects in cell morphology and division at 32 °C or 41.4 °C, respectively 13 . At the non-permissive temperature, the double mutant formed spherical cells that phenocopied the defect caused by severe depletion of PcsB 13 . The three-dimensional structure of PcsB shows that these mutations are located in the leucine zipper regions and are involved in the interaction between α1 and α3 (Leu 79) and in the interaction between α4 and α3 (Leu218) (Supplementary Fig.15) . Thus, the alteration in the CC architecture caused by these amino acid changes probably perturbs the activation mechanism of PcsB and locks the mutant protein in an inactive state, although we can not discard other possibilities such as the mutant is unstable and degraded, or that mutations in the CC domain could alter the length of the protein or its orientation relative to the cytoplasmic membrane.
The conserved FtsEX complex recently emerged as a major regulator of PG hydrolysis during bacterial cell division 13, 15, 32 . FtsEX is essential or conditionally essential in a great variety of bacterial species 14, 33 . FtsEX structurally resembles an ABC transporter 34 , but recent studies indicate that FtsEX acts as a signal transduction system rather than as a transporter of an unknown substrate 33 . The 3D structure of PcsB provides clues to how regulation/activation by the FtsEX complex can take place (Fig. 5) . The dimeric arrangement of PcsB precludes any lytic activity unless the CHAP domain is released, in a controlled way, from the CC domain. To release the CHAP domain, the "molecular tweezers", which consists of α1-α3 on one side and α4-α5 on the other, must be opened on both sides. Previous studies involving Ts and suppressor mutants of PcsB and FtsX, respectively, revealed mutations in the large (ECL1) and small (ECL2) extracellular loops of FtsX which indicate that the FtsX-PcsB interaction occurs between these loops and the CC domain of PcsB 13, 14 . The Ts mutations in CC PcsB are located just in the middle of α1 and α3 helices and at the base of α4 helix (Supplementary Fig.15 ), while the connecting regions in FtsX involve the distal portion of the ECL1 and ECL2 loops 14 .
These results point to a specific interaction between the FtsX loops and both sides of the "molecular tweezers". The energy required for the coordinated movement of α helices in the CC PcsB domain is in all likelihood produced by hydrolysis of ATP by FtsE. In agreement with this, it has been shown that the conserved amino acids in the ATP binding site of FtsE are essential for pneumococcal growth, supporting the idea that ATPase activity by FtsE is required for FtsEX→PcsB signaling and coordination of cell separation 14 . Once released, the catalytic domain would not require further opening of the active-site loops. We have demonstrated that CHAP alone exhibits hydrolytic activity and presents a pre-formed 31-Å groove that can accommodate the cross-linked peptide stems (Fig. 5c) . Our docking calculations allowed us to map the different subsites of substrate-peptide recognition for
PcsB. Especially relevant is the presence of an acidic patch that could explain PcsB's specificity for L-Lys containing stem-peptides ( Fig. 2b and Supplementary Fig. 9 ).
Further studies on hydrolytic activity of PcsB are however required to precisely identify the cleavage site of this enzyme.
Our TEM studies of intermediately and severely PcsB-depleted cells show that the synthesis of new cross walls continues unimpeded in the absence of PcsB, suggesting that the cross wall splitting machinery operates independently of the septal peptidoglycan synthesis machinery. What controls the activity of the cross wall splitting machinery to ensure that it acts at the right time and place? As discussed above, evidence strongly supports that ATP hydrolysis by FtsE provides the energy needed to activate PcsB.
However, as ATP is abundant in the cytoplasm throughout the cell cycle, the availability of this nucleotide cannot be a factor that controls splitting of the cross wall. In principle, the level of PcsB, FtsX FtsE or possibly other hitherto unknown members of the cell wall splitting machinery could be tightly regulated in a cell cycle dependent manner, but so far no evidence of such regulation has been reported. In our view the unusual dimeric structure of PcsB is a striking characteristic that must serve a critical function in the in vivo sides that make it possible to insert PcsB from the compartment of each daughter cell so that the molecules will meet in the middle and dimerize. This would represent an ingenious control mechanism. Due to the net-like polymeric structure of peptidoglycan, the mobility of PcsB dimers is probably restricted. Thus, it is likely that PcsB, which is a moderately abundant protein in the pneumococcal cell (about ~5000 monomers per cell, 12 ), only acts locally and is then discarded. This is supported by the fact that relatively large amounts of PcsB are released to the medium during growth 12 . In sum, our results indicate that the unique modular structure and dimeric organization of PcsB have evolved to allow precise splitting of the septum during cell division, while avoiding damage to other parts of the peptidoglycan sacculus.
Accession codes.
Atomic coordinates and structure factors for native PcsB have been deposited in the Protein Data Bank with accession code 4CGK. 
METHODS
Bacterial growth and transformation
Strains of Escherichia coli were grown in Luria Bertani medium at 37 or 28°C with shaking in the presence of 100 µg/ml ampicillin when appropriate. E. coli was transformed by heat shock as described by Sambrook and Russell 35 . S. pneumoniae strain R6 and S. gordonii strain Challis were grown without shaking at 37°C in C medium 36 and Todd-Hewitt medium (Difco), respectively. Construction of S. pneumoniae mutants was performed by natural transformation. Briefly, pneumococcal cultures were cultivated at 37°C until they reached OD 550 = 0.05-0.1. Then, transforming DNA and 250 ng/ml of synthetic competence stimulating peptide (CSP1) were added. After further incubation at 37°C for 120 min, transformants were selected on Todd-Hewitt plates containing the appropriate antibiotic; kanamycin (400 µg/ml) or streptomycin (200 µg/ml).
Expression and purification of mature PcsB
PcsB was purified by using the tandem affinity tag called CHiC-tag as previously described by Stamsås et al. 37 followed by ion exchange chromatography. In brief, pcsB fused to the CHiC-tag by overlap extension PCR 38 was cloned into the expression vector pRSET A (Invitrogen) resulting in pGS01 37 . E. coli BL21 (DE3) (Invitrogen) containing the plasmid pGS01 (strain gs32, see Supplementary Table 3 then bound on to an anion exchanger (Sepharose Q, GE Healthcare) and eluted by gradually increasing the NaCl concentration from 0 to 500 mM in a 25 ml gradient. The flow-rate was set to 1 ml/min. The fractions containing >99% pure PcsB were pooled and concentrated by using Amicon Ultra-15 Centrifugal Filter Units (Millipore).
Cloning and production of SeMet-PcsB
A SeMet derivative of PcsB was produced in order to solve the phase problem associated with the structure determination of native PcsB. Since mature PcsB only contains two methionines per 365 residues (M140 and M150), we introduced two additional methionines by replacing the residues Q180 and L250 with M. Methionine codons were introduced at codon 180 and 250 by overlap extension PCR 38 . For the CAA180 to ATG180 (Q180M) substitution, base pairs 535-1179 of pcsB were amplified using the forward primer ds85 and the T7 revers primer producing PCR product 1 (Primers are listed in Supplementary Table 4 ). The region corresponding to base pairs 1-559 of pcsB fused 5' to the CHiC-tag was amplified using the T7 forward primer and revers primer ds86 producing PCR product 2. The plasmid pGS01 37 served as template in both reactions. Since primer ds85 is complementary to primer ds86, PCR product 1 and 2 were fused in an overlap extension PCR by using the flanking primers T7 forward and T7 revers generating PCR product 3.
To introduce the additional CTT250 to ATG250 (L250M) substitution, base pairs 748-1179 of pcsB were amplified using forward primer ds79 and T7 revers primer producing PCR product 4. Similarly region 1-773 of pcsB fused 5' to the CHiC-tag was amplified using the T7 forward primer and revers primer ds80 to generate PCR product 5. PCR product 3 was used as template in both reactions. PCR fragment 4 and 5 were fused in an overlap extension PCR using the T7 forward and T7 revers primers. This generated PCR fragment 6 which contained a Q180M and L250M version of PcsB fused N-terminally to the CHiCtag. This mutated version of PcsB will be referred to as PcsB mut . Fragment 6 was cleaved with XbaI and EcoRI and ligated immediately downstream of the T7lac promoter in pRSET A giving rise to plasmid pGS214.
For production of SeMet-PcsB mut , E. coli BL21 (DE3) harboring pGS214 (strain ds122, see Supplementary Table 3 To construct the pcsB-CHAP lytF chimeric gene, pneumococcal pcsB without its CHAP encoding part (bp 1-858) was amplified using the primer pair 216/52 and genomic DNA from strain RH1 40 as template. The CHAP encoding part of lytF (bp 1260-1578) was amplified using the primer pair 53/217 and genomic DNA from S. gordonii (Challis) as template. These two fragments were fused by overlap extension PCR using the primer pair 216/217 producing the fragment pcsB-CHAP lytF . Next, ~1000-bp fragments corresponding to the 5' and 3' flanking regions of pcsB were amplified with the primer pairs 37/218 and 219/38, respectively. Genomic DNA from the RH1 strain was used as template. By overlap extension PCR the 5' flanking region was fused to the 5' end of the pcsB-CHAP lytF gene using the primer pair 37/217. Similarly, the 3' flanking region was fused to the 3' end of pcsB-CHAP lytF using the primer pair 216/38. Finally, these two fragments were fused using the primers 37 and 38.
To test if PcsB-CHAP lytF could substitute for wild type PcsB in S. pneumoniae we wanted to replace the native pcsB gene with the chimeric pcsB-CHAP lytF gene. As pcsB is an essential gene in S. pneumoniae R6, an extra copy of the wild type gene had to be expressed ectopically before the native pcsB gene could be removed and replaced by a Janus cassette 41 . For ectopic expression of pcsB we employed the R6 derivative SPH131, which has the ComRS expression/depletion system integrated in its genome 30 . First, the pcsB gene was amplified with the primers 35 and 36 and DNA from strain RH1 as template. Next, fragments corresponding to the ~1000-bp upstream and downstream regions of the Janus cassette in strain SPH131 were amplified using the primer pairs khb31/khb36 and khb33/khb34, respectively. Then, by the use of overlap extension PCR with the primers khb31 and 36, the pcsB fragment was fused to the upstream fragment.
Similarly, the pcsB fragment was fused to the downstream fragment by using the primers 35 and khb34. Finally these two fragments were fused using the primer pair khb31/khb34.
By replacing the Janus cassette in SPH131 with the resulting PCR product strain SPH246 was generated.
Before the pcsB-CHAP lytF gene could be introduced into the native pcsB locus, the native pcsB gene was replaced with the Janus cassette. The Janus cassette was amplified with the primers Kan484.F and RpsL41.R and genomic DNA from strain RH426 42 as template. Fragments (~1000 bp) corresponding to the 5' and 3' regions of the native pcsB gene was amplified using the primer pairs 37/39 and 40/38, respectively. DNA from strain RH1 was used as template. The resulting fragments were then fused to the Janus cassette in separate PCR reactions. The 5' flanking region was fused to the Janus cassette using the primers 37 and RpsL41.R, while the 3' flanking region was fused to the Janus cassette with the primers Kan484.F and 38. Finally, these two fragments were fused together using the primers 37 and 38. By transforming strain SPH246 with a PCR fragment corresponding to the Janus cassette flanked by the upstream and downstream regions of the pcsB gene, strain SPH247 was obtained. Transformants of SPH247 was grown in the presence 1 µM ComS* to drive ectopic expression of PcsB. Next, the Janus cassette in SPH247 was replaced with the pcsB-CHAP lytF fragment described above, giving rise to strain SPH248.
For removal of the ectopically expressed copy of WT pcsB in strain SPH248, this gene and its P comX promoter was replaced by a Janus cassette. Genomic DNA from strain SPH154 43 , which contains a Janus cassette inserted in the ectopic locus, served as template to amplify a PCR fragment consisting of the Janus cassette plus ~1000 bp flanking regions.
The PCR reaction was carried out with the primers khb31 and khb34. The resulting fragment was transformed into strain SPH248, generating strain SPH249. Finally, the Janus cassette was removed by transforming strain SPH249 with a fragment containing only the flanking regions of the Janus cassette. The 5' and the 3' region of the Janus cassette were amplified using the primer pairs khb31/khb32 and 154/khb34, respectively.
DNA from SPH154 served as template. These two fragments were fused by overlap extension PCR using the primer pair khb31/khb34. The resulting fragment was transformed into strain SPH249, giving rise to strain SPH250.
To construct lytF-CHAP pcsB the region (bp 76-1332) encoding the cell wall binding domain of LytF (without its 25 aa leader sequence) was amplified using the primer pair ds95/ds96 and DNA from S. gordonii strain Challis as template. The CHAP-encoding region of PcsB (bp 859-1179) was amplified using the primer pair ds97/ds98 and DNA from S. pneumoniae RH1 as template. These two fragments were fused in an overlap extension PCR with the flanking primers ds95 and ds98 resulting in a lytF-CHAP pcsB chimera. LytF-CHAP PcsB was expressed in S. pneumoniae by using the ComRS system described by Berg and co-workers 30 . The 5' and 3' regions of the Janus cassette in strain SPH131 (see above) were amplified by the primer pairs khb31/khb36 and khb33/khb34, respectively, and then fused to the 5' and 3' ends of the lytF-CHAP pcsB fragment by overlap extension PCR using the primers khb31 and khb34. The resulting fragment was transformed into strain SPH131, replacing the Janus cassette and giving rise to strain SPH252.
To construct His-CHAP PcsB we amplified the CHAP encoding part of pcsB using the primers ds147 and T7 revers primer and the plasmid pGS01 37 as template. The C292A mutated version of CHAP PcsB was amplified using the same primers but with genomic DNA from SPH258 as template. Primer ds147 contains a 6xHis encoding part. The PCR products were cleaved with XbaI and EcoRI and ligated in to pRSET A immediately downstream of the T7lac promoter. The resulting plasmids were transformed into E. coli BL21 (DE3) giving rise to strain ds179 and ds189.
Zymogram analysis
The muralytic activity of LytF-CHAP PcsB , His-CHAP PcsB and His-CHAP PcsB(C292A) was Similarly, the activity of His-CHAP PcsB and its C292A mutated counterpart were examined in zymogram gels containing S. pneumoniae strain RH14 as substrate. His-CHAP PcsB and His-CHAP PcsB(C292A) were expressed in E. coli strain ds179 and ds189
respectively by adding a final concentration of 0.1 mM IPTG at OD 600 = 0.3 followed by incubation at 28°C for 4 h. A volume of 500 ml induced ds179 cells were collected by centrifugation at 5000 x g for 5 min. The cells were then resuspended in 5 ml of 10 mM
Tris-HCl, pH 7.4 containing 100 mM NaCl. The cells were lysed by adding lysozyme to a final concentration of 1 mg/ml followed by 10 min at 37°C. His-CHAP PcsB and His-CHAP PcsB(C292A) were purified from the soluble protein fraction by using Protino ® Ni-TED150 (Macherey-Nagel) columns as described by the manufacturer. The purified proteins were then separated by SDS-PAGE in 13% zymogram gels before the gels were incubated in refolding buffer.
Transmission electron microscopy. 55 . In all cases, the good quality of all electron density maps allowed modeling the most part of the polypeptide chain, ligands and solvent molecules (see Table   1 ). The first 40 amino acids from the N-terminal tail were disordered and were not visible in the structure and the short helix α2 presented a poor electron density especially in one of the monomers. In the crystal structure of the native PcsB the electron density map clearly defines a polyethylene glycol moiety attached to the active site of chain B. The figures were generated by using PyMol (Molecular Graphics System, Version 1.5.0.4 Schrödinger, LLC.).
Docking calculations
The structure of the pneumococcal peptidoglycan peptide stem fragment L-Ala-D-isoGln-L-Lys-D-Ala was modeled using pymol. Charges assignment and optimization was carried in chimera 56 . Molecular docking was carried using GOLD (Genetic Optimization for Ligand Docking) software 25 , using the genetic algorithm (GA). The PEG ligand found in the crystal structure was used as starting point for cavity detection. For each of the 25 independent GA runs, a maximum number of 100,000 GA operations were performed on a set of five groups with a population size of 100 individuals. Default cut-off values of 2.5 (dH-X) for hydrogen bonds and 4.0 for Van Deer Waals distance were employed.
When the top three solutions attained RMSD values within 1.5 , GA docking was terminated. The RMSD values for the docking calculations are based on the RMSD matrix of the ranked solutions. Best-ranked solutions were always among the first 10 GA runs, and the conformation of molecules based on the best fitness score was further analyzed.
Analytical Ultracentrifugation.
Sedimentation velocity was used in combination with sedimentation equilibrium to determine the association state of protein PcsB over a broad range of concentrations (0.1-8.0 mg/ml). Sedimentation velocity runs were carried out at 48,000 rpm and 20 °C in an XL-I analytical ultracentrifuge (Beckman-Coulter Inc.) equipped with UV-VIS and Raleigh interference detection system, using an An50Ti rotor and 3 and 12 mm double sector centerpieces (sample in the range of 0.1-1.0 mg/ml were loaded in normal 12 mm centerpiece and samples in the range of 2.0-8.0 mg/ml in narrow 3 mm centerpieces).
The sedimentation coefficient distributions were calculated by least squares boundary modeling of sedimentation velocity data using the c(s) method 57 as implemented in the SEDFIT program. Calculated s values were corrected to standard conditions (water, 20
°C, and infinite dilution) using the SEDNTERP program 58 and the concentration dependence of s, to get the corresponding standard s values. Short column (21-85 µl, depending of the centerpieces) equilibrium runs were carried out at multiple speeds (8,000, 12,000, and 15,000 rpm) and the corresponding scans were measured at the appropriate wavelength. Whole cell apparent weight-average buoyant molecular weight of the protein samples were determined by fitting a single species model to the experimental data using the HeteroAnalysis program 59 . The corresponding protein molecular weights were calculated from the experimental buoyant values using 0.722 cm 3 /g as the protein partial specific volume. Several models of self-association were globally fitted to multiple sedimentation equilibrium using the HeteroAnalysis program.
To assign the most probable structure of the main protein species present, the standard s-values experimentally obtained were compared with the s-values determined for given structural models using the shell-model calculation implemented in HYDROPRO 60 .
SAXS experiments.
SAXS data were collected at the EMBL beamline BM29 at the ESRF (Grenoble, France), using a robotic sample changer, from six sample solutions of PcsB at concentrations ranging from 0.29-9.40 mg ml -1 in 10 mM Tris-HCl pH 7.4 and 5% glycerol at 277 K. Data were recorded using a photon-counting Pilatus 1M pixel detector (DECTRIS, Switzerland)
at a sample-detector distance of 2.7 m and a wavelength of λ = 1 Å. The scattering intensity I(q) was recorded in a range of the momentum transfer 0.01 < q < 0.6 Å −1
(where q = 4π sinθ/λ, and 2θ is the scattering angle). Sample solutions were circulated in a thermostatic flow mode during the measurement to minimize radiation damage effects.
Ten frames of 1 s exposures were collected for each sample, normalized to the transmitted intensity, and subsequently averaged using AUTOSUB. In PRIMUS, the forward scattering I(0) and the radii of gyration Rg were estimated using the Guinier approximation I(q) = I(0) exp(−(qRg) 2 /3) with qRg < 1.3. These parameters were also computed from the entire scattering patterns using the indirect transform package GNOM, providing also the pair-distance distribution function P(r), from which the maximum particle dimension, Dmax, was estimated. The molecular weight was calculated from excluded volume of the hydrated particle (the Porod volume, Vp). The ab initio modeling programs DAMMIN and DAMMIF were used for low-resolution shape generation, and 10 models were calculated in the slow mode, and averaged with DAMAVER, which also provides a value of normalized spatial discrepancy (NSD) representing a measure of similarity among different models. The theoretical profile from the high-resolution structure of PcsB was computed with CRYSOL. The ab initio model was superimposed with the high-resolution structure using the program SUPCOMB. All the SAXS programs and calculation modules are included in the ATSAS programs package 61 . 
